文献速递糖尿病

LADA与1型糖尿病的代谢组学差异:色氨酸代谢参与自身免疫糖尿病异质性

Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes.
PubMed 文献 · Diabetologia · 2026-06-26

本研究对49例LADA、44例1型糖尿病、29例类风湿关节炎和14例对照者进行代谢组与脂质组分析,并评估细胞因子处理的胰岛。结果显示LADA与1型糖尿病在脂质组和代谢组存在差异,色氨酸代谢激活标志物Kyn/Trp在自身免疫病中高于对照,且从RA到LADA再到1型糖尿病呈递减趋势,提示LADA中免疫耐受通路激活受损较轻,与其β细胞丢失程度较轻一致。

要点

  • LADA与1型糖尿病在磷脂酰乙醇胺、神经酰胺等脂质及TCA循环入口代谢物上存在差异。
  • Kyn/Trp比值在对照组最低,RA最高,LADA居中,1型糖尿病低于LADA。
  • LADA中Kyn/Trp与空腹C肽水平独立正相关。

核心结论

  • LADA与1型糖尿病的代谢组和脂质组谱不同,色氨酸代谢参与自身免疫糖尿病异质性。
  • LADA中色氨酸代谢通路激活受损程度较1型糖尿病轻,与其β细胞丢失较轻一致。

研究设计与样本

  • 横断面比较研究,纳入136人:49例LADA、44例1型糖尿病、29例类风湿关节炎、14例对照。
  • 对健康供者胰岛进行促炎细胞因子体外处理后的组学评估。

主要发现

  • 1型糖尿病中磷脂酰乙醇胺、神经酰胺、溶血磷脂酰胆碱及TCA循环入口代谢物高于LADA。
  • 促炎细胞因子处理的胰岛中色氨酸浓度降低80%。
  • Kyn/Trp比值中位数:对照组0.014(0.012-0.019),RA 0.027(0.022-0.032),LADA 0.021(0.018-0.024),1型糖尿病0.018(0.014-0.022),ANCOVA p<0.0001。
  • LADA中Kyn/Trp与空腹C肽在多变量回归模型中直接相关(p=0.038)。

临床怎么用

  • 色氨酸代谢通路激活标志物Kyn/Trp可能有助于区分LADA与1型糖尿病的免疫代谢异质性。
  • LADA中Kyn/Trp与空腹C肽正相关,提示该通路激活程度与β细胞功能保留相关。

局限性

  • 样本量较小(共136人),各组人数不等。
  • 横断面设计无法确定因果关系。
  • 胰岛体外实验使用促炎细胞因子处理,与体内环境存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The heterogeneity of autoimmune diabetes may be associated with variable metabolic alterations. Our aim was to investigate differences in the metabolomic and lipidomic profile of autoimmune diseases and to identify pathways linked to beta cell damage. To this end, we compared latent autoimmune diabetes in adults (LADA) and type 1 diabetes, also comparing them with rheumatoid arthritis (RA), a related autoimmune condition, and healthy control participants. METHODS: Metabolomic and lipidomic analyses were performed for 136 individuals (49 with LADA, 44 with type 1 diabetes, 29 with RA and 14 control participants). Omics of pancreatic islets from healthy donors were also evaluated after in vitro treatment with proinflammatory cytokines. RESULTS: LADA and type 1 diabetes differed from RA in terms of lipidomics and metabolomics. Phosphatidylethanolamines, ceramides, lysophosphatidylcholine and several metabolites at the entry sites of the tricarboxylic acid cycle were higher in type 1 diabetes compared with LADA. In pancreatic islets treated with proinflammatory cytokines, tryptophan concentration was reduced by 80%, indicating the activation of tryptophan metabolism in response to the inflammatory stimulus. In people with autoimmune disorders, kynurenine/tryptophan ratio (Kyn/Trp), a marker of tryptophan pathway activation, was higher than in the control group (Kyn/Trp ratio in control group, median [25th-75th percentile]: 0.014 [0.012-0.019]), with a progressive decline from RA (0.027 [0.022-0.032]) to LADA (0.021 [0.018-0.024]) and then to type 1 diabetes (0.018 [0.014-0.022]), ANCOVA p<0.0001. In LADA, Kyn/Trp was directly associated with fasting C-peptide levels in the multivariate regression model accounting for confounders (p=0.038). CONCLUSIONS/INTERPRETATION: Metabolomic and lipidomic profiles differ between LADA and type 1 diabetes and vs RA, providing new insights into the heterogeneity of autoimmune diabetes. Our results confirm the involvement of tryptophan metabolism in autoimmune disorders, suggesting that the impaired activation of this pathway of immune tolerance in LADA is less pronounced than in type 1 diabetes, consistent with its milder degree of beta cell loss.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Maddaloni E, Pezzica S, Amendolara R, et al. Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes. Diabetologia. 2026. PMID: 42360463. doi:10.1007/s00125-026-06777-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。